Total Payments
$1,924
2024 Payments
$215.33
Companies
14
Transactions
64
Medicare Patients
3,729
Medicare Billing
$681,074
Payment Breakdown by Category
Food & Beverage$1,924 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,924 | 64 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $471.02 | 16 | $0 (2020) |
| Otsuka America Pharmaceutical, Inc. | $356.46 | 3 | $0 (2019) |
| ABBVIE INC. | $255.50 | 12 | $0 (2024) |
| Alkermes, Inc. | $249.59 | 2 | $0 (2018) |
| BioXcel Therapeutics, Inc. | $148.29 | 3 | $0 (2023) |
| PFIZER INC. | $99.58 | 7 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $97.82 | 7 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $82.45 | 6 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $34.49 | 2 | $0 (2024) |
| CSL Behring | $34.46 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $215.33 | 10 | ABBVIE INC. ($174.80) |
| 2023 | $148.29 | 3 | BioXcel Therapeutics, Inc. ($148.29) |
| 2022 | $144.52 | 7 | ABBVIE INC. ($80.70) |
| 2020 | $34.89 | 2 | AcelRx Pharmaceuticals, Inc. ($22.41) |
| 2019 | $220.28 | 9 | Otsuka America Pharmaceutical, Inc. ($118.39) |
| 2018 | $645.56 | 20 | Allergan Inc. ($250.65) |
| 2017 | $514.93 | 13 | Otsuka America Pharmaceutical, Inc. ($238.07) |
All Payment Transactions
64 individual payment records from CMS Open Payments — Page 2 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/30/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $12.45 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/15/2019 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $11.54 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/03/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.53 | General |
| Category: Cardiovascular | ||||||
| 03/13/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.58 | General |
| Category: Cardiovascular | ||||||
| 02/06/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.52 | General |
| Category: Cardiovascular | ||||||
| 02/05/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug), SIVEXTRO | Food and Beverage | In-kind items and services | $11.53 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/13/2018 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 11/12/2018 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 11/01/2018 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $8.88 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/31/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 10/16/2018 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: CNS | ||||||
| 09/27/2018 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $63.27 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/28/2018 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/28/2018 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $11.41 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/09/2018 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $10.92 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/24/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 07/12/2018 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $9.31 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/25/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 05/15/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 03/23/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.07 | General |
| Category: Cardiovascular | ||||||
| 03/20/2018 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $135.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/14/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $12.35 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 02/14/2018 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $4.02 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/12/2018 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Food and Beverage | In-kind items and services | $124.59 | General |
| Category: CNS | ||||||
| 01/17/2018 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $7.84 | General |
| Category: ANTI-INFECTIVE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 777 | 813 | $1.2M | $134,321 |
| 2022 | 4 | 1,004 | 1,069 | $1.5M | $204,099 |
| 2021 | 4 | 1,050 | 1,112 | $1.6M | $191,069 |
| 2020 | 4 | 898 | 958 | $1.3M | $151,584 |
Total Patients
3,729
Total Services
3,952
Medicare Billing
$681,074
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 499 | 529 | $776,043 | $90,093 | 11.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 140 | 142 | $267,528 | $29,660 | 11.1% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 116 | 120 | $119,520 | $13,219 | 11.1% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 22 | 22 | $11,550 | $1,349 | 11.7% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 693 | 751 | $1.1M | $152,248 | 13.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 120 | 123 | $231,732 | $30,668 | 13.2% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 157 | 161 | $160,356 | $18,750 | 11.7% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 34 | 34 | $17,850 | $2,433 | 13.6% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 793 | 846 | $1.2M | $151,451 | 12.2% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 109 | 110 | $207,240 | $23,461 | 11.3% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 111 | 119 | $118,524 | $13,513 | 11.4% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 37 | 37 | $19,425 | $2,644 | 13.6% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 653 | 703 | $1.0M | $117,840 | 11.4% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 87 | 89 | $167,676 | $19,682 | 11.7% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 69 | 72 | $71,712 | $8,168 | 11.4% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 89 | 94 | $49,350 | $5,893 | 11.9% |
About Dr. Paul Taglienti, MD
Dr. Paul Taglienti, MD is a Emergency Medicine healthcare provider based in Stony Brook, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/10/2008. The National Provider Identifier (NPI) number assigned to this provider is 1447410840.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paul Taglienti, MD has received a total of $1,924 in payments from pharmaceutical and medical device companies, with $215.33 received in 2024. These payments were reported across 64 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($1,924).
As a Medicare-enrolled provider, Taglienti has provided services to 3,729 Medicare beneficiaries, totaling 3,952 services with total Medicare billing of $681,074. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency Medicine
- Location Stony Brook, NY
- Active Since 06/10/2008
- Last Updated 12/06/2022
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1447410840
Products in Payments
- DALVANCE (Drug) $668.17
- Aristada 441 mg (Drug) $249.59
- ABILIFY MAINTENA (Drug) $238.07
- IGALMI (Drug) $148.29
- REXULTI (Drug) $118.39
- ZERBAXA (Drug) $97.82
- ELIQUIS (Drug) $97.50
- CHANTIX (Drug) $84.53
- TEFLARO (Drug) $58.35
- Kcentra (Biological) $34.46
- Kimyrsa (Drug) $30.06
- DSUVIA (Drug) $22.41
- XARELTO (Drug) $22.11
- KENGREAL (Drug) $19.56
- ANDEXXA (Biological) $18.42
- BRILINTA (Drug) $16.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Stony Brook
Dr. Adam Singer, M.d, M.D
Emergency Medicine — Payments: $675,767
Emergency Medicine $675,767
Dr. Jose Torres, Md, MD
Emergency Medicine — Payments: $1,565
Emergency Medicine $1,565
Dr. Lawrence Schiff, Md, MD
Emergency Medicine — Payments: $1,071
Emergency Medicine $1,071
Dr. Joseph Corcoran, Md, MD
Emergency Medicine — Payments: $813.09
Emergency Medicine $813.09
Dr. Sayed Khwaja, D.o, D.O
Emergency Medicine — Payments: $612.51
Emergency Medicine $612.51
Dr. Jerome Wilkerson, M.d, M.D
Emergency Medicine — Payments: $499.23
Emergency Medicine $499.23